NL-OMON49490尚未招募2 期
Treatment of metastatic vulvar carcinoma in a neoadjuvant setting with Carboplatin and Paclitaxel chemotherapy - CRAVAT
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Woman >= 18 years
- •Signed and written informed consent.
- •Histologically confirmed squamous cell vulvar carcinoma
- •World Health Organization performance status of 0-2
- •Adequate hematological function
- •Adequate hepatic function
- •Adequate renal function
- •Negative pregnancy test for woman of childbearing potential
- •Histologically or CT scan confirmed metastatic squamous cell vulvar carcinoma
- •Measurable disease
- •TNM stage any T any N M1
排除标准
- •Vulvar cancer other than squamous cell carcinoma at biopsy
- •Patients with metastasis limited to the pelvic lymph nodes, who can be
- •primarily operated with curative intent
- •Other diagnosis of malignancy or evidence of other malignancy for 5 years
- •before screening for this study
研究者
相似试验
进行中（未招募）
1 期
Treatment of metastatic vulvar carcinoma in a neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyEUCTR2019-000851-15-NLKI-AV12
进行中（未招募）
1 期
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerCTIS2024-510865-41-00Aarhus Universitetshospital282
招募中
2 期
Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel ChemotherapyMetastatic Squamous Cell Carcinoma of the VulvaNCT04161664The Netherlands Cancer Institute12
招募中
2 期
Treatment of locally advanced VULvar CArcinoma in a Neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyNL-OMON48481Antoni van Leeuwenhoek Ziekenhuis51
进行中（未招募）
1 期
Treatment of locally advanced VULvar CArcinoma in a Neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyEUCTR2019-003104-12-NLKI-AV51